Related Experiment Videos
Regulation of HDM2 activity by the ribosomal protein L11
Marion A E Lohrum1, Robert L Ludwig, Michael H G Kubbutat
1Regulation of Cell Growth Laboratory, NCI-FRCDC, Frederick, MD 21702, USA.
Abstract:
The HDM2 protein plays an important role in regulating the stability and function of the p53 tumor suppressor protein. In this report, we show that the ribosomal protein L11 can interact with HDM2 and inhibit HDM2 function, thus leading to the stabilization and activation of p53. The inhibition of HDM2 activity by L11 shows some similarity to the previously described activity of ARF, and expression of either ARF or L11 can induce a p53 response. Enhancement of the interaction between endogenous L11 and HDM2 following treatment of cells with low levels of actinomycin-D suggests that the HDM2/L11 interaction represents a novel pathway for p53 stabilization in response to perturbations in ribosome biogenesis.
Insights
Ribosomal protein L11 stabilizes the p53 tumor suppressor by inhibiting HDM2. This discovery reveals a new pathway for p53 activation linked to ribosome biogenesis, crucial for cancer research.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cellular Regulation
Background:
- The HDM2 protein is a key regulator of the p53 tumor suppressor protein's stability and function.
- Understanding p53 regulation is critical for developing cancer therapies.
Purpose of the Study:
- To investigate the interaction between ribosomal protein L11 and HDM2.
- To elucidate the role of this interaction in p53 stabilization and activation.
Main Methods:
- Co-immunoprecipitation assays to detect protein interactions.
- Cell-based assays to assess p53 stabilization and activation.
- Treatment with actinomycin-D to induce perturbations in ribosome biogenesis.
Main Results:
- Ribosomal protein L11 directly interacts with HDM2, inhibiting its function.
- L11 binding leads to the stabilization and activation of p53.
- The HDM2/L11 interaction is enhanced upon treatment with low-dose actinomycin-D, suggesting a role in ribosome biogenesis stress response.
Conclusions:
- Ribosomal protein L11 represents a novel mechanism for p53 stabilization.
- The HDM2/L11 pathway offers a new target for modulating p53 activity in cancer.
- This interaction highlights a link between ribosome biogenesis and tumor suppression.